Neomycin, Polymyxin B And Bacitracin Zinc
29 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
29
Total Reports
1
Deaths Reported
340.0%
Death Rate
Active Ingredients
Neomycin, Polymyxin B And Bacitracin Zinc
Administration Routes
OphthalmicIntraocularUnknownTopicalOral
Species Affected
Dog 27
Cat 2
Most Affected Breeds
Retriever - Labrador 3
Boxer (German Boxer) 2
Shih Tzu 2
Crossbred Canine/dog 2
Pug 2
Bulldog 1
Spaniel - Tibetan 1
Mastiff 1
Spitz - American Eskimo Dog 1
Bichon Frise 1
Most Reported Reactions
Ocular discharge 7
Vomiting 6
Diarrhoea 6
Other abnormal test result NOS 5
Emesis 4
Lack of efficacy - NOS 4
Blepharospasm 4
Corneal ulcer 4
Weight loss 3
Hyperphosphataemia 3
Nasal discharge 3
Schirmer tear test 3
Outcome Breakdown
Outcome Unknown
13 (44.8%)
Recovered/Normal
8 (27.6%)
Ongoing
7 (24.1%)
Euthanized
1 (3.4%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.